These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 32458667)

  • 1. Postdischarge antidiabetic treatment in patients with type 2 diabetes and acute coronary syndrome: time for a change?
    Patoulias D; Papadopoulos C; Toumpourleka M; Bakatselos S; Doumas M
    Kardiol Pol; 2020 May; 78(5):482-483. PubMed ID: 32458667
    [No Abstract]   [Full Text] [Related]  

  • 2. Post-discharge antidiabetic treatment in patients with type 2 diabetes and acute coronary syndrome: time for a change? Authors' reply.
    Niedziela JT; Strojek K; Gąsior M
    Kardiol Pol; 2020 May; 78(5):482-483. PubMed ID: 32458666
    [No Abstract]   [Full Text] [Related]  

  • 3. Prevalence, characteristics, and prognostic implications of type 2 diabetes in patients with myocardial infarction: the Polish Registry of Acute Coronary Syndromes (PL‑ACS) annual 2018 report.
    Niedziela JT; Hiczkiewicz J; Kleinrok A; Pączek P; Leszek P; Lelonek M; Rozentryt P; Parma Z; Witkowski A; Bartuś S; Zdrojewski T; Buszman P; Kaźmierczak J; Strojek K; Gąsior M
    Kardiol Pol; 2020 Mar; 78(3):243-246. PubMed ID: 32063598
    [No Abstract]   [Full Text] [Related]  

  • 4. Glucose-lowering therapy and cardiovascular outcomes in patients with type 2 diabetes mellitus and acute coronary syndrome.
    Avogaro A; Bonora E; Consoli A; Del Prato S; Genovese S; Giorgino F
    Diab Vasc Dis Res; 2019 Sep; 16(5):399-414. PubMed ID: 31044622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship Between β-Blocker Therapy at Discharge and Clinical Outcomes in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention.
    Li C; Sun Y; Shen X; Yu T; Li Q; Ruan G; Zhang L; Huang Q; Zhuang H; Huang J; Ni L; Wang L; Jiang J; Wang Y; Wang DW
    J Am Heart Assoc; 2016 Nov; 5(11):. PubMed ID: 27852588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetic patients with acute coronary syndromes in contemporary European registries: characteristics and outcomes.
    Lettino M; Andell P; Zeymer U; Widimsky P; Danchin N; Bardaji A; Barrabes JA; Cequier A; Claeys MJ; De Luca L; Dörler J; Erlinge D; Erne P; Goldstein P; Koul SM; Lemesle G; Lüscher TF; Matter CM; Montalescot G; Radovanovic D; Sendón JL; Tousek P; Weidinger F; Weston CFM; Zaman A; Li J; Jukema JW;
    Eur Heart J Cardiovasc Pharmacother; 2017 Oct; 3(4):198-213. PubMed ID: 28329196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of Characteristics and Data Elements Requirements in National Acute Coronary Syndrome Registries for Postdischarge Follow-up.
    Sadeqi Jabali M; Farzandipour M; Nabovati E; Sarrafzadegan N; Sadeghi M
    Curr Probl Cardiol; 2023 Aug; 48(8):101244. PubMed ID: 35545177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A risk score to predict postdischarge bleeding among acute coronary syndrome patients undergoing percutaneous coronary intervention: BRIC-ACS study.
    Chen Y; Yin T; Xi S; Zhang S; Yan H; Tang Y; Qian J; Chen J; Su X; Du Z; Wang L; Qin Q; Gao C; Zheng Y; Zhao X; Cheng X; Li Z; Zhang W; Chen H; Wang J; Yang Z; Li H; Liu H; Zhou X; Qu B; Xiang D; Guo Y; Wang L; Nie S; Fu G; Yang M; Cai S
    Catheter Cardiovasc Interv; 2019 Jun; 93(7):1194-1204. PubMed ID: 31112635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lixisenatide in Type 2 Diabetes and Acute Coronary Syndrome.
    Derosa G; Maffioli P
    N Engl J Med; 2016 Mar; 374(11):1095. PubMed ID: 26981947
    [No Abstract]   [Full Text] [Related]  

  • 10. [Acute coronary syndrome in patients with type 2 diabetes mellitus].
    Ametov AS; P'ianykh OP; Aslandziia EN
    Ter Arkh; 2011; 83(9):66-70. PubMed ID: 22145391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discharge heart rate and mortality after acute myocardial infarction.
    Seronde MF; Geha R; Puymirat E; Chaib A; Simon T; Berard L; Drouet E; Bataille V; Danchin N; Schiele F
    Am J Med; 2014 Oct; 127(10):954-62. PubMed ID: 25004457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temporal trends in secondary prevention in myocardial infarction patients discharged with left ventricular systolic dysfunction in Poland.
    Gasior M; Gierlotka M; Pyka Ł; Zdrojewski T; Wojtyniak B; Chlebus K; Rozentryt P; Niedziela J; Jankowski P; Nessler J; Opolski G; Hoffman P; Jankowska E; Polonski L; Ponikowski P
    Eur J Prev Cardiol; 2018 Jun; 25(9):960-969. PubMed ID: 29692221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current patterns of antithrombotic and revascularisation therapy in patients hospitalised for acute coronary syndromes. Data from the Polish subset of the EPICOR study.
    Wojtkowska I; Stępińska J; Stępień-Wojno M; Sobota M; Kopaczewski J; Reszka Z; Kurzelewski M; Medina J
    Kardiol Pol; 2017; 75(5):445-452. PubMed ID: 28281731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prevalence, predictors and outcomes of guideline-directed medical therapy in patients with acute myocardial infarction undergoing PCI, an analysis from the PROMETHEUS registry.
    Ge Z; Baber U; Claessen BE; Farhan S; Chandrasekhar J; Li SX; Sartori S; Kini AS; Rao SV; Weiss S; Henry TD; Vogel B; Sorrentino S; Faggioni M; Kapadia S; Muhlestein B; Strauss C; Toma C; DeFranco A; Effron MB; Keller S; Baker BA; Pocock S; Dangas G; Mehran R
    Catheter Cardiovasc Interv; 2019 Feb; 93(3):E112-E119. PubMed ID: 30351514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of an antidiabetic treatment with sulfonylurea drugs on long-term survival after acute myocardial infarction in patients with type 2 diabetes. The LAngendreer Myocardial infarction and Blood glucose in Diabetic patients Assessment (LAMBDA).
    Meier JJ; Deifuss S; Klamann A; Schmiegel W; Nauck MA;
    Exp Clin Endocrinol Diabetes; 2003 Sep; 111(6):344-50. PubMed ID: 14520601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Discharge Aspirin Dose With Outcomes After Acute Myocardial Infarction: Insights From the Treatment with ADP Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events after Acute Coronary Syndrome (TRANSLATE-ACS) Study.
    Xian Y; Wang TY; McCoy LA; Effron MB; Henry TD; Bach RG; Zettler ME; Baker BA; Fonarow GC; Peterson ED
    Circulation; 2015 Jul; 132(3):174-81. PubMed ID: 25995313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Copeptin and insulin-like growth factor binding protein-1 during follow-up after an acute myocardial infarction in patients with type 2 diabetes: A report from the Diabetes Mellitus Insulin-Glucose Infusion in Acute Myocardial Infarction 2 cohort.
    Smáradóttir MI; Catrina SB; Brismar K; Norhammar A; Gyberg V; Mellbin LG
    Diab Vasc Dis Res; 2019 Jan; 16(1):22-27. PubMed ID: 30309264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence, predictors, and subsequent mortality risk of recurrent myocardial infarction in patients following discharge for acute myocardial infarction.
    Nakatani D; Sakata Y; Suna S; Usami M; Matsumoto S; Shimizu M; Sumitsuji S; Kawano S; Ueda Y; Hamasaki T; Sato H; Nanto S; Hori M; Komuro I;
    Circ J; 2013; 77(2):439-46. PubMed ID: 23075765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetes mellitus and cardiovascular events in older patients with myocardial infarction prescribed intensive-dose and moderate-dose statins.
    Ko DT; Wijeysundera HC; Jackevicius CA; Yousef A; Wang J; Tu JV
    Circ Cardiovasc Qual Outcomes; 2013 May; 6(3):315-22. PubMed ID: 23674307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prevalence of diabetes, antidiabetic treatment and chronic diabetic complications reported by general practitioners].
    Fabian W; Majkowska L; Stefański A; Moleda P
    Przegl Lek; 2005; 62(4):201-5. PubMed ID: 16229234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.